title: Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment).
abstract: OBJECTIVE
  The goals were to compare early school-age neurodevelopmental and respiratory outcomes for children who were treated with either early (<3 days) or delayed selective (>15 days) postnatal corticosteroid therapy and to compare systemic dexamethasone treatment with inhaled budesonide treatment.
  
  
  METHODS
  One hundred twenty-seven (84%) of 152 survivors from the United Kingdom and Ireland who were recruited to the Open Study of Early Corticosteroid Treatment, a randomized trial of inhaled and systemic corticosteroid therapy to prevent chronic lung disease, were traced and assessed at a median age of 7 years. Outcome measures were level of disability, presence of cerebral palsy, cognitive ability, behavioral difficulties and competencies, growth, and respiratory symptoms. Results were adjusted for potential confounding variables (gestational age, birth weight, gender, prenatal steroid therapy, method of delivery, Apgar score at 5 minutes, and Clinical Risk Index for Babies score).
  
  
  RESULTS
  There were no significant differences among the treatment groups in cognitive ability, behavioral competencies or difficulties, overall disability rates, cerebral palsy, combined outcomes of death or cerebral palsy and death or moderate/severe disability, growth, respiratory morbidity, or diastolic blood pressure. Those assigned to dexamethasone were more likely to have high systolic blood pressure and to have a diagnosis of asthma than were those assigned to budesonide.
  
  
  CONCLUSIONS
  Although postnatal steroid therapy has been associated with poor long-term outcomes, this study failed to show significant differences in cognitive function between dexamethasone- and budesonide-allocated groups. There may be increased systolic blood pressure and a greater likelihood of developing asthma in childhood after postnatal dexamethasone treatment.
authors.affiliation: Regional Neonatal Unit, Royal Maternity Hospital, Belfast BT12 6BB, Northern Ireland.
authors.forename: Trevor T
authors.initials: TT
authors.lastname: Wilson
authors.forename: Lorraine
authors.initials: L
authors.lastname: Waters
authors.forename: Chris C
authors.initials: CC
authors.lastname: Patterson
authors.forename: Chris G
authors.initials: CG
authors.lastname: McCusker
authors.forename: Nichola M
authors.initials: NM
authors.lastname: Rooney
authors.forename: Neil
authors.initials: N
authors.lastname: Marlow
authors.forename: Henry L
authors.initials: HL
authors.lastname: Halliday
mesh_terms: D000280:Administration, Inhalation; D000367:Age Factors; D019819:Budesonide / Q000008:administration & dosage*; D002648:Child; D002657:Child Development; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007494:Ireland; D008171:Lung Diseases / Q000517:prevention & control*; D008297:Male; D009420:Nervous System / Q000254:growth & development*; D006113:United Kingdom
chemical_list: D005938:Glucocorticoids; D019819:Budesonide; D003907:Dexamethasone